Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma

NCT00901069 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shams Shakil

Collaborators